PrENT: Prevalence of ENT Diseseas

Sponsor
Medical University of Graz (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06105346
Collaborator
(none)
10,000
28

Study Details

Study Description

Brief Summary

The aim of the present study will be to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.

Therefore, questionnaires and data of medical examinations, aquired routinely at the military induction board, will be analysed.

Detailed Description

Rhinosinusitis is a very common complaint at ENT departments, whereby symptoms of the underlying disease are varying. Therefore, there is growing interest in prevalence of rhinosinusitis including differences in prevalence's depending on where the patient grew up. Further, there is growing interest in answering the question if different factors, including ENT-surgeries in medical history have an impact on symptoms of rhinosinusitis.

Within the past few years there is growing interest in carring out as many HPV-vaccinations as possible in order to reduce the prevalence of HPV-associated cancers.

Further, in adolescents there is a growing number of hearing impairments, including hearing loss and/or sounds in the ears.

Next, since the beginning of the COVID pandemic there are very common complaints in adult and pediatric patients about persistent medical problems for weeks or months after an acute SARS-CoV-2-infection and cannot be explained by another diagnosis, called long- Covid disease.

The military induction board of conscripts enables access to data from a cross-section of the population, with common characteristics of gender and age.

In the present study we want therefore to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
10000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prevalence Study of ENT-related Diseases in Conscripts at the Military Induction Board
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Mar 31, 2026

Outcome Measures

Primary Outcome Measures

  1. Prevalence of rhinosinusitis [Through data collection, an average of 1 week]

    To assess whether there is a difference in prevalence of rhinosinusitis in urban-bred conscripts compared to non-urban-bred conscripts.

  2. Prevalence of human papilloma virus vaccination [Through data collection, an average of 1 week]

    To assess whether there is a difference in prevalence of human papilloma virus vaccinations in urban-bred conscripts compared to non-urban-bred conscripts.

  3. Prevalence of hearing impairment [Through data collection, an average of 1 week]

    To assess whether there is a difference in prevalence of hearing impairment in urban-bred conscripts compared to non-urban-bred conscripts.

  4. Prevalence of long-COVID disease [Through data collection, an average of 1 week]

    To assess whether there is a difference in prevalence of long-COVID disease in vaccinated conscripts compared to no-vaccinated conscripts.

Secondary Outcome Measures

  1. Prevalence of rhinosinusitis [Through data collection, an average of 1 week]

    To assess prevalence of rhinosinusitis in conscripts at the military induction board

  2. Prevalence of rhinosinusitis [Through data collection, an average of 1 week]

    To assess the different symptoms of rhinosinusitis in conscripts at the military induction board

  3. Prevalence of rhinosinusitis [Through data collection, an average of 1 week]

    To assess the prevalence of rhinosinusitis in conscripts with previous ENT-surgeries

  4. Prevalence of rhinosinusitis [Through data collection, an average of 1 week]

    To assess differences in symptoms in rhinosinusitis in conscripts with previous ENT-surgeries

  5. Prevalence of rhinosinusitis [Through data collection, an average of 1 week]

    To assess the combined prevalence of rhinosinusitis and chronic pulmonary diseases in conscripts

  6. Prevalence of rhinosinusitis [Through data collection, an average of 1 week]

    To assess the difference in prevalence of subjective symptoms of rhinosinusitis compared to objective (apparatus based and laboratory based) symptoms of rhinosinusitis

  7. Prevalence of rhinosinusitis [Through data collection, an average of 1 week]

    To analyse demographic data in conscripts with rhinosinusitis

  8. Prevalence of human papilloma virus vaccines [Through data collection, an average of 1 week]

    To assess the prevalence of HPV vaccines among conscripts at the military induction board

  9. Prevalence of human papilloma virus vaccines [Through data collection, an average of 1 week]

    To assess knowledge about HPV and HPV vaccinations and in dependent of that prevalence of HPV vaccines among conscripts at the military induction board

  10. Prevalence of hearing impairment [Through data collection, an average of 1 week]

    To assess the prevalence of hearing impairment in conscripts at the military induction board

  11. Prevalence of hearing impairment [Through data collection, an average of 1 week]

    To assess the difference in prevalence of subjective symptoms of hearing impairment compared to objective (apparatus based and laboratory based) signs of hearing impairment

  12. Prevalence of hearing impairment [Through data collection, an average of 1 week]

    To analyse demographic data in conscripts with hearing impairment

  13. Prevalence of long-COVID [Through data collection, an average of 1 week]

    To assess the prevalence of long-COVID in conscripts at the military induction board

  14. Prevalence of long-COVID [Through data collection, an average of 1 week]

    To assess different symptoms of long-COVID in conscripts at the military induction board

  15. Prevalence of COVID-19 infection [Through data collection, an average of 1 week]

    To assess the prevalence of previous COVID 19 infections in conscripts at the military induction board

  16. Prevalence of long-COVID [Through data collection, an average of 1 week]

    To analyse demographic data in conscripts with long-COVID

Eligibility Criteria

Criteria

Ages Eligible for Study:
17 Years to 19 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • participation of the military induction board of conscripts

  • consent for participation obtained by the conscripts

  • completed questionnaire (with at least 50% completeness of each subcategory)

  • participation of medical examination

Exclusion Criteria:
  • no consent for participation in the study by the conscripts

  • incomplete questionnaire (with less than 50% completeness of each subcategory)

  • no participation of medical examination.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Medical University of Graz

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medical University of Graz
ClinicalTrials.gov Identifier:
NCT06105346
Other Study ID Numbers:
  • PrENT v1
First Posted:
Oct 27, 2023
Last Update Posted:
Oct 27, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Medical University of Graz
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 27, 2023